USPTO serial 79018255
APOMAB
Reviewed by CopyMark Law Group
Reg. 3356510Status 404
- Filing date
- Status date
- Registration date
- Dec 18, 2007
- Examiner
- HELLMAN, ELI J
- Law office
- GENERIC WEB UPDATE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with APOMAB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ronald E. Shapiro
Ronald E. Shapiro Shapiro and Silverstein PLLC11350 Random Hills Road, Suite 740FAIRFAX, VA 22030UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products and preparations of antibodies, immunoreactive and/or antigen-binding fragments of antibodies, or direct modifications, conjugates or functionalized derivatives of antibodies, for health care, all the foregoing for the treatment of malignant, inflammatory and autoimmune disorders and conditions, tissue trauma and tissue ischaemia; pharmaceutical products and preparations of antibodies, immunoreactive and/or antigen-binding fragments of antibodies, or direct modifications, conjugates or functionalized derivatives of antibodies, for radio-immuno-diagnosis or radio-immuno-therapy, the foregoing for the diagnosis and treatment of malignant, inflammatory and autoimmune disorders and conditions, tissue trauma and tissue ischaemia; pharmaceutical preparations used in the therapy and diagnosis of malignant, inflammatory and autoimmune disorders and conditions, tissue trauma and tissue ischaemia; diagnostic preparations for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions, tissue trauma and tissue ischaemia in humans, the foregoing for medical use; monoclonal antibodies and fragments thereof for cancer research and pharmaceutical development, biomedical research, [ veterinary vaccines, ]veterinary diagnostic and treatment purposes, clinical trials for cancer pharmaceuticals, cancer diagnosis and cancer therapy purposes; cultures and preparations of hybridoma and other cells for medical, diagnostic and veterinary purposes; medicinal products of antibodies, immunoreactive and/or antigen-binding fragments of antibodies, or direct modifications, conjugates or functionalized derivatives of antibodies, the foregoing for the treatment of malignant, inflammatory and autoimmune disorders and conditions, tissue trauma and tissue ischaemia | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 12, 2026 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Feb 12, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Nov 30, 2025 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Nov 30, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 1, 2019 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 19, 2018 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 6, 2018 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 6, 2018 | INPC | INVALIDATION PROCESSED | — |
| Aug 21, 2018 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 21, 2017 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Dec 21, 2017 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Dec 15, 2017 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Dec 18, 2016 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| May 21, 2015 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Dec 26, 2013 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Dec 26, 2013 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Dec 26, 2013 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 10, 2013 | 715F | REGISTERED - SEC. 71 & SEC. 15 FILED | — |
| Dec 10, 2013 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Jun 4, 2009 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 2, 2008 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 2, 2008 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 18, 2008 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 18, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 2, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 12, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 27, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 21, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 21, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Aug 21, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 3, 2007 | ALIE | ASSIGNED TO LIE | — |
| Jun 29, 2007 | PAPER RECEIVED | — | |
| Jun 7, 2007 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 24, 2007 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 24, 2007 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 19, 2007 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 19, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 21, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Mar 20, 2007 | ALIE | ASSIGNED TO LIE | — |
| Feb 12, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 12, 2007 | PAPER RECEIVED | — | |
| Aug 14, 2006 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 14, 2006 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 25, 2006 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jun 26, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 26, 2006 | PAPER RECEIVED | — | |
| Jan 27, 2006 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 10, 2006 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 31, 2005 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 30, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 27, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 27, 2005 | NWAP | NEW APPLICATION ENTERED | — |
| Dec 22, 2005 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |